Eye Cancers Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

MC1R-targeted Alpha-particle Therapy Trial in Adults With Advanced Melanoma
Conditions:   Melanoma (Skin);   Metastatic Melanoma;   Melanoma Stage IV;   Melanoma, Uveal;   Mucosal Melanoma;   Melanoma Stage III Intervention:   Drug: [212Pb]VMT01 Sponsor:   Viewpoint Molecular Targeting Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2022 Category: Research Source Type: clinical trials

TAS-116 Plus Palbociclib in Breast and Rb-null Cancer
Conditions:   Advanced Breast Cancer;   Treatment-Refractory Solid Tumors;   Retinoblastoma Deficiency;   SCLC;   Soft Tissue Sarcoma;   Endometrial Cancer;   Bladder Cancer Interventions:   Drug: Palbociclib Oral Product;   Drug: TAS-116 Sponsors:   Brown University;   Taiho Oncology, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2022 Category: Research Source Type: clinical trials

MC1R-targeted Alpha-particle Therapy Trial in Adults With Advanced Melanoma
Conditions:   Melanoma (Skin);   Metastatic Melanoma;   Melanoma Stage IV;   Melanoma, Uveal;   Mucosal Melanoma;   Melanoma Stage III Intervention:   Drug: [212Pb]VMT01 Sponsor:   Viewpoint Molecular Targeting Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2022 Category: Research Source Type: clinical trials

TAS-116 Plus Palbociclib in Breast and Rb-null Cancer
Conditions:   Advanced Breast Cancer;   Treatment-Refractory Solid Tumors;   Retinoblastoma Deficiency;   SCLC;   Soft Tissue Sarcoma;   Endometrial Cancer;   Bladder Cancer Interventions:   Drug: Palbociclib Oral Product;   Drug: TAS-116 Sponsors:   Brown University;   Taiho Oncology, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2022 Category: Research Source Type: clinical trials

MC1R-targeted Alpha-particle Therapy Trial in Adults With Advanced Melanoma
Conditions:   Melanoma (Skin);   Metastatic Melanoma;   Melanoma Stage IV;   Melanoma, Uveal;   Mucosal Melanoma;   Melanoma Stage III Intervention:   Drug: [212Pb]VMT01 Sponsor:   Viewpoint Molecular Targeting Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2022 Category: Research Source Type: clinical trials

TAS-116 Plus Palbociclib in Breast and Rb-null Cancer
Conditions:   Advanced Breast Cancer;   Treatment-Refractory Solid Tumors;   Retinoblastoma Deficiency;   SCLC;   Soft Tissue Sarcoma;   Endometrial Cancer;   Bladder Cancer Interventions:   Drug: Palbociclib Oral Product;   Drug: TAS-116 Sponsors:   Brown University;   Taiho Oncology, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2022 Category: Research Source Type: clinical trials

MC1R-targeted Alpha-particle Therapy Trial in Adults With Advanced Melanoma
Conditions:   Melanoma (Skin);   Metastatic Melanoma;   Melanoma Stage IV;   Melanoma, Uveal;   Mucosal Melanoma;   Melanoma Stage III Intervention:   Drug: [212Pb]VMT01 Sponsor:   Viewpoint Molecular Targeting Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2022 Category: Research Source Type: clinical trials

TAS-116 Plus Palbociclib in Breast and Rb-null Cancer
Conditions:   Advanced Breast Cancer;   Treatment-Refractory Solid Tumors;   Retinoblastoma Deficiency;   SCLC;   Soft Tissue Sarcoma;   Endometrial Cancer;   Bladder Cancer Interventions:   Drug: Palbociclib Oral Product;   Drug: TAS-116 Sponsors:   Brown University;   Taiho Oncology, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2022 Category: Research Source Type: clinical trials

MC1R-targeted Alpha-particle Therapy Trial in Adults With Advanced Melanoma
Conditions:   Melanoma (Skin);   Metastatic Melanoma;   Melanoma Stage IV;   Melanoma, Uveal;   Mucosal Melanoma;   Melanoma Stage III Intervention:   Drug: [212Pb]VMT01 Sponsor:   Viewpoint Molecular Targeting Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2022 Category: Research Source Type: clinical trials

TAS-116 Plus Palbociclib in Breast and Rb-null Cancer
Conditions:   Advanced Breast Cancer;   Treatment-Refractory Solid Tumors;   Retinoblastoma Deficiency;   SCLC;   Soft Tissue Sarcoma;   Endometrial Cancer;   Bladder Cancer Interventions:   Drug: Palbociclib Oral Product;   Drug: TAS-116 Sponsors:   Brown University;   Taiho Oncology, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2022 Category: Research Source Type: clinical trials

MC1R-targeted Alpha-particle Therapy Trial in Adults With Advanced Melanoma
Conditions:   Melanoma (Skin);   Metastatic Melanoma;   Melanoma Stage IV;   Melanoma, Uveal;   Mucosal Melanoma;   Melanoma Stage III Intervention:   Drug: [212Pb]VMT01 Sponsor:   Viewpoint Molecular Targeting Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2022 Category: Research Source Type: clinical trials

TAS-116 Plus Palbociclib in Breast and Rb-null Cancer
Conditions:   Advanced Breast Cancer;   Treatment-Refractory Solid Tumors;   Retinoblastoma Deficiency;   SCLC;   Soft Tissue Sarcoma;   Endometrial Cancer;   Bladder Cancer Interventions:   Drug: Palbociclib Oral Product;   Drug: TAS-116 Sponsors:   Brown University;   Taiho Oncology, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2022 Category: Research Source Type: clinical trials

MC1R-targeted Alpha-particle Therapy Trial in Adults With Advanced Melanoma
Conditions:   Melanoma (Skin);   Metastatic Melanoma;   Melanoma Stage IV;   Melanoma, Uveal;   Mucosal Melanoma;   Melanoma Stage III Intervention:   Drug: [212Pb]VMT01 Sponsor:   Viewpoint Molecular Targeting Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2022 Category: Research Source Type: clinical trials

TAS-116 Plus Palbociclib in Breast and Rb-null Cancer
Conditions:   Advanced Breast Cancer;   Treatment-Refractory Solid Tumors;   Retinoblastoma Deficiency;   SCLC;   Soft Tissue Sarcoma;   Endometrial Cancer;   Bladder Cancer Interventions:   Drug: Palbociclib Oral Product;   Drug: TAS-116 Sponsors:   Brown University;   Taiho Oncology, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2022 Category: Research Source Type: clinical trials

MC1R-targeted Alpha-particle Therapy Trial in Adults With Advanced Melanoma
Conditions:   Melanoma (Skin);   Metastatic Melanoma;   Melanoma Stage IV;   Melanoma, Uveal;   Mucosal Melanoma;   Melanoma Stage III Intervention:   Drug: [212Pb]VMT01 Sponsor:   Viewpoint Molecular Targeting Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2022 Category: Research Source Type: clinical trials